广州市丰华生物工程有限公司 email format

Founded in 1999 and developed from a small distributer, Guangzhou Fenghua Bioengineering Co., Ltd. (hereunder called FENGHUA) is a leading Chinese in vitro diagnostic reagents and instruments manufacturer and distributor. Located in the Guangzhou Development District, which is at the center of the golden delta of Guangzhou, Hong Kong andMacao. FENGHUA occupies an area of ten thousand square meters, and owns a GMP standard manufactory workshop of one thousand square meters and an office building. FENGHUA is the first company which developed TRFIA devices and reagents based on microplate inChinaand have a capability to supply more than 50 Millions of tests of IVD kits annually. Our research and marketing efforts extend to the fields of prenatal screening, neonatal screening and routine clinical immunoassay. FENGHUA has 14 years of experiences, strong R&D abilities, integrated technical and customer-oriented marketing support, year-by-year excellent financial status and prospective future and reliable social and business partners. Now, more than 50 products (including reagents and instruments) are registered by China Food and Drug Administration (CFDA) before market release. Each diagnostic reagents and instruments is rigorously tested to ensure it meets our high quality standards and your satisfaction. And we are No. 1 among domestic manufactures and No. 2 among all manufactures in prenatal screening and neonatal screening fields and No. 2 among domestic manufactures in No. 2 among domestic manufactures in the field of quantitative detection of hepatitis B inChina. Our customers include hospitals, maternal and child health care, health examination center, community health service center, commercial laboratories.